{"success":true,"data":{"pressRelease":{"id":"175548","rtpr_id":"nGNX6V0mRb-20261021","ticker":"HSCS","exchange":"NASDAQ","all_tickers":["HSCS","HSCSW"],"title":"HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining","author":"Globe Newswire","published_at":"2026-10-21T12:30:00.805Z","article_body":"* Definitive proxy statement filed with the SEC, marking an important\nmilestone toward completion of the proposed transaction\n* HeartSciences Board of Directors unanimously recommends shareholders vote\nFOR the transaction-related proposals\n* Proposed combination expected to establish a publicly traded,\nvertically-integrated digital asset mining platform focused on Zcash, subject\nto shareholder approval and other closing conditions\nSOUTHLAKE, Texas, Oct. 21, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc.\n(Nasdaq: HSCS; HSCSW) (\"HeartSciences\" or the \"Company\"), an AI-powered\nmedical technology company, today announced that it has filed its definitive\nproxy statement on Schedule 14A (the \"Definitive Proxy Statement\") with the\nU.S. Securities and Exchange Commission (\"SEC\") in connection with its\npreviously announced proposed business combination with Fortitude Mining\nHoldings, Inc. (\"Fortitude\"), a vertically-integrated digital asset mining\nplatform anchored in Zcash (the \"Proposed Transaction\").\n\nThe filing of the Definitive Proxy Statement represents an important milestone\ntoward completing the Proposed Transaction, which was initially announced on\nJune 23, 2026.\n\nHeartSciences has scheduled a Special Meeting of Shareholders for November 19,\n2026, at 10:00 a.m. Eastern Time, to consider and vote upon the Proposed\nTransaction and related proposals. Shareholders of record as of October 8,\n2026, are entitled to vote at the meeting.\n\nThe HeartSciences Board of Directors has unanimously approved the\ntransaction-related proposals and recommends that shareholders vote FOR each\nproposal, as more fully described in the Definitive Proxy Statement.\n\nProposed Business Combination\n\nUnder the terms of the definitive merger agreement, HeartSciences and\nFortitude have agreed to combine in an all-stock transaction.\n\nUpon completion of the Proposed Transaction, the combined company is expected\nto operate under the Fortitude brand, with its Class A common stock expected\nto trade on Nasdaq under the ticker symbol \"TUDE,\" subject to applicable\nlisting requirements and Nasdaq approval.\n\nFortitude operates an institutional-scale, vertically-integrated digital asset\nmining platform, combining mining operations, data center infrastructure, and\npower assets, with a strategic focus on Zcash.\n\nCompletion of the Proposed Transaction remains subject to HeartSciences\nshareholder approval, applicable Nasdaq listing requirements and other\ncustomary closing conditions.\n\nSpecial Meeting and Shareholder Voting\n\nThe Special Meeting will be conducted virtually on November 19, 2026, at 10:00\na.m. Eastern Time.\n\nShareholders may access the meeting at:\nhttps://edge.media-server.com/mmc/p/ztcy99wt The Definitive Proxy Statement\nand accompanying proxy materials are being distributed to eligible\nshareholders and provide information regarding the Proposed Transaction, the\nproposals to be voted upon, voting procedures and other relevant matters.\n\nEligible shareholders are encouraged to carefully review the Definitive Proxy\nStatement and submit their votes promptly, whether or not they intend to\nparticipate in the Special Meeting.\n\nRegistered shareholders may vote in advance through the procedures described\nin their proxy materials, including online at www.voteproxy.com. Shareholders\nholding shares through banks, brokers or other nominees should follow the\ninstructions provided on their voting instruction form.\n\nIf you have any questions or need assistance voting your shares, please\ncontact our proxy solicitor, Okapi Partners LLC, at:\n\n\n1212 Avenue of the Americas, 17(th) Floor\nNew York, NY 10036\nToll-Free: (855) 208-8902\nor\nE-mail: info@okapipartners.com\n\nThe Definitive Proxy Statement is available free of charge through the SEC's\nwebsite at www.sec.gov, linked for ease of access here\n(https://www.globenewswire.com/Tracker?data=XCQW1iOIFtGdySZGfY4ZyOR_LzB0uG6MkK6YNjXYqgx7sVn-5Gf6djn8pb4XciMlYyo7YXyFM8-AlVdHwix1NL8E0-Ql1VQaBEFYvsoYo5R-Ei_JnoKljaEWu5Fimb-aNNVB0YxRbe8fKmLh2fxB_MsbKrsLlQrGelHqIxNeK6Y=).\n\nAdditional Information About the Proposed Transaction and Where to Find It\n\nThis press release constitutes a communication in connection with the Proposed\nTransaction and may be deemed solicitation material in respect of the Proposed\nTransaction.\n\nOn October 19, 2026, HeartSciences filed the Definitive Proxy Statement with\nthe SEC and may file additional relevant materials with the SEC from time to\ntime. HeartSciences is mailing the Definitive Proxy Statement and a proxy card\nto shareholders entitled to vote at the Special Meeting relating to the\nProposed Transaction.\n\nINVESTORS AND SHAREHOLDERS OF HEARTSCIENCES ARE URGED TO READ THE DEFINITIVE\nPROXY STATEMENT, INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO, AND ALL\nOTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH\nTHE PROPOSED TRANSACTION BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT\nHEARTSCIENCES, FORTITUDE AND THE PROPOSED TRANSACTION.\n\nThis press release does not contain all the information that should be\nconsidered concerning the Proposed Transaction and related matters and is not\nintended to provide the basis for any investment decision or other decision\nconcerning such matters.\n\nInvestors and shareholders may obtain copies of the Definitive Proxy Statement\nand other relevant filings free of charge at www.sec.gov or by submitting a\nrequest to HeartSciences Investor Relations at\ninvestorrelations@heartsciences.com.\n\nCautionary Note Regarding Forward-Looking Information\n\nThis press release contains forward-looking statements concerning\nHeartSciences, Fortitude, the Proposed Transaction and other matters.\n\nForward-looking statements may be identified by terms such as \"anticipate,\"\n\"expect,\" \"plan,\" \"will,\" \"would,\" \"believe,\" \"estimate,\" \"goal,\" \"intend,\"\nand similar expressions. Statements other than historical facts should be\nconsidered forward-looking statements.\n\nThese statements include, without limitation, expectations regarding the\ntiming and completion of the Proposed Transaction, the anticipated benefits of\nthe Proposed Transaction, the future operations and strategy of the combined\ncompany, and the expected Nasdaq listing and trading symbol.\n\nForward-looking statements are based on management's current expectations and\nassumptions and are subject to risks, uncertainties and other factors that\ncould cause actual outcomes to differ materially from those expressed or\nimplied.\n\nThese risks include, among others:\n* The possibility that the Proposed Transaction may not be completed on the\nanticipated timeline or at all;\n* Failure to satisfy closing conditions, including obtaining the necessary\nHeartSciences shareholder approvals and applicable Nasdaq listing approvals;\n* Market, macroeconomic and business conditions affecting HeartSciences,\nFortitude or the combined company;\n* Risks associated with integrating operations and managing a newly public\ncompany;\n* Risks related to Fortitude's mining operations, including the substantial\nvolatility of Zcash and other digital asset prices; and\n* Legal, commercial, regulatory and technical uncertainties associated with\ndigital assets.\nAdditional risks and uncertainties are described in the Definitive Proxy\nStatement, HeartSciences' Annual Report on Form 10-K filed July 23, 2026, its\nQuarterly Report on Form 10-Q filed September 14, 2026, and other SEC filings.\n\nReaders are cautioned not to place undue reliance on forward-looking\nstatements. HeartSciences and Fortitude undertake no obligation to update or\nrevise forward-looking statements except as required by applicable law. All\nforward-looking statements speak only as of the date of this release.\n\nParticipants in the Solicitation\n\nHeartSciences and Fortitude, their respective directors and executive\nofficers, and certain executive officers of Digital Currency Group (“DCG”)\n, Fortitude's parent company, may be deemed participants in the solicitation\nof proxies from HeartSciences shareholders in connection with the Proposed\nTransaction.\n\nInformation regarding these participants and their direct or indirect\ninterests in the Proposed Transaction, whether through securities holdings or\notherwise, is described in the Definitive Proxy Statement and other relevant\nSEC filings.\n\nAbout Fortitude\n\nFortitude, currently wholly owned by DCG, is an institutional-scale,\nvertically-integrated venture mining platform operating across the\nProof-of-Work ecosystem and anchored in Zcash. Fortitude pairs self-mining\noperations with an owned data center footprint, a diversified power portfolio\nbacked by competitive long-term contracts, and disciplined capital allocation\nto identify and scale high-conviction opportunities in emerging Proof-of-Work\necosystems, beginning with its leadership position in the Zcash network.\nFortitude is led by an experienced team of operators, capital markets\nprofessionals, and digital asset specialists with a track record of\nidentifying and scaling high-conviction opportunities and building\nprivacy-preserving digital asset infrastructure.\n\nFor more information, visit www.fortitudemining.com and follow Fortitude on X\nat @FortitudeCrypto\n\nIn the ordinary course of business, Fortitude currently sells or otherwise\nmonetizes all the digital assets that it mines, including ZEC. In addition,\nFortitude and its affiliates and subsidiaries, including DCG, from time to\ntime sell, pledge or otherwise monetize their digital asset holdings,\nincluding ZEC. The funds received from such sales, pledges, or other\nmonetization activities are used to fund operating expenses and capital\ninvestments, as well as for other purposes, including to hedge exposures and\nrealize investment gains.\n\nAbout HeartSciences Inc.\n\nHeartSciences is a healthcare information technology company advancing the use\nof electrocardiography (\"ECG\" or \"EKG\") through the integration of artificial\nintelligence. HeartSciences' MyoVista Insights™ platform is a\ndevice-agnostic ECG management system designed to improve clinical efficiency\nand decision-making. Its MyoVista wavECG device is designed to deliver\nconventional ECG functionality while supporting AI-enabled solutions.\n\nFor more information, visit www.heartsciences.com\n\nInvestor Relations Contact\nIntegrous Communications\nMark Komonoski, Partner\nPhone: 877 255 8483\nEmail: mkomonoski@integcom.us \n\nEmail: investorrelations@heartsciences.com\n\nFortitude Investor Relations and Media Contact:\nICR\nPhone: 917-375-9457\nEmail: IR@fortitudemining.com\n\nA photo accompanying this announcement is available at\nhttps://www.globenewswire.com/NewsRoom/AttachmentNg/dd7e1d4a-bc27-4a05-baa5-902736cdec1b\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/800a6aae-74f3-42bb-9199-5e169ed9b881)\nOkapi Partners LLC Logo \n(https://www.globenewswire.com/NewsRoom/AttachmentNg/dd7e1d4a-bc27-4a05-baa5-902736cdec1b/en)\nOkapi Partners LLC Logo\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX6V0mRb-20261021","title":"HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining","author":"Globe Newswire","ticker":"HSCS","created":"2026-10-21T12:30:00.805Z","tickers":["HSCS","HSCSW"],"exchange":"NASDAQ","article_body":"* Definitive proxy statement filed with the SEC, marking an important\nmilestone toward completion of the proposed transaction\n* HeartSciences Board of Directors unanimously recommends shareholders vote\nFOR the transaction-related proposals\n* Proposed combination expected to establish a publicly traded,\nvertically-integrated digital asset mining platform focused on Zcash, subject\nto shareholder approval and other closing conditions\nSOUTHLAKE, Texas, Oct. 21, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc.\n(Nasdaq: HSCS; HSCSW) (\"HeartSciences\" or the \"Company\"), an AI-powered\nmedical technology company, today announced that it has filed its definitive\nproxy statement on Schedule 14A (the \"Definitive Proxy Statement\") with the\nU.S. Securities and Exchange Commission (\"SEC\") in connection with its\npreviously announced proposed business combination with Fortitude Mining\nHoldings, Inc. (\"Fortitude\"), a vertically-integrated digital asset mining\nplatform anchored in Zcash (the \"Proposed Transaction\").\n\nThe filing of the Definitive Proxy Statement represents an important milestone\ntoward completing the Proposed Transaction, which was initially announced on\nJune 23, 2026.\n\nHeartSciences has scheduled a Special Meeting of Shareholders for November 19,\n2026, at 10:00 a.m. Eastern Time, to consider and vote upon the Proposed\nTransaction and related proposals. Shareholders of record as of October 8,\n2026, are entitled to vote at the meeting.\n\nThe HeartSciences Board of Directors has unanimously approved the\ntransaction-related proposals and recommends that shareholders vote FOR each\nproposal, as more fully described in the Definitive Proxy Statement.\n\nProposed Business Combination\n\nUnder the terms of the definitive merger agreement, HeartSciences and\nFortitude have agreed to combine in an all-stock transaction.\n\nUpon completion of the Proposed Transaction, the combined company is expected\nto operate under the Fortitude brand, with its Class A common stock expected\nto trade on Nasdaq under the ticker symbol \"TUDE,\" subject to applicable\nlisting requirements and Nasdaq approval.\n\nFortitude operates an institutional-scale, vertically-integrated digital asset\nmining platform, combining mining operations, data center infrastructure, and\npower assets, with a strategic focus on Zcash.\n\nCompletion of the Proposed Transaction remains subject to HeartSciences\nshareholder approval, applicable Nasdaq listing requirements and other\ncustomary closing conditions.\n\nSpecial Meeting and Shareholder Voting\n\nThe Special Meeting will be conducted virtually on November 19, 2026, at 10:00\na.m. Eastern Time.\n\nShareholders may access the meeting at:\nhttps://edge.media-server.com/mmc/p/ztcy99wt The Definitive Proxy Statement\nand accompanying proxy materials are being distributed to eligible\nshareholders and provide information regarding the Proposed Transaction, the\nproposals to be voted upon, voting procedures and other relevant matters.\n\nEligible shareholders are encouraged to carefully review the Definitive Proxy\nStatement and submit their votes promptly, whether or not they intend to\nparticipate in the Special Meeting.\n\nRegistered shareholders may vote in advance through the procedures described\nin their proxy materials, including online at www.voteproxy.com. Shareholders\nholding shares through banks, brokers or other nominees should follow the\ninstructions provided on their voting instruction form.\n\nIf you have any questions or need assistance voting your shares, please\ncontact our proxy solicitor, Okapi Partners LLC, at:\n\n\n1212 Avenue of the Americas, 17(th) Floor\nNew York, NY 10036\nToll-Free: (855) 208-8902\nor\nE-mail: info@okapipartners.com\n\nThe Definitive Proxy Statement is available free of charge through the SEC's\nwebsite at www.sec.gov, linked for ease of access here\n(https://www.globenewswire.com/Tracker?data=XCQW1iOIFtGdySZGfY4ZyOR_LzB0uG6MkK6YNjXYqgx7sVn-5Gf6djn8pb4XciMlYyo7YXyFM8-AlVdHwix1NL8E0-Ql1VQaBEFYvsoYo5R-Ei_JnoKljaEWu5Fimb-aNNVB0YxRbe8fKmLh2fxB_MsbKrsLlQrGelHqIxNeK6Y=).\n\nAdditional Information About the Proposed Transaction and Where to Find It\n\nThis press release constitutes a communication in connection with the Proposed\nTransaction and may be deemed solicitation material in respect of the Proposed\nTransaction.\n\nOn October 19, 2026, HeartSciences filed the Definitive Proxy Statement with\nthe SEC and may file additional relevant materials with the SEC from time to\ntime. HeartSciences is mailing the Definitive Proxy Statement and a proxy card\nto shareholders entitled to vote at the Special Meeting relating to the\nProposed Transaction.\n\nINVESTORS AND SHAREHOLDERS OF HEARTSCIENCES ARE URGED TO READ THE DEFINITIVE\nPROXY STATEMENT, INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO, AND ALL\nOTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH\nTHE PROPOSED TRANSACTION BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT\nHEARTSCIENCES, FORTITUDE AND THE PROPOSED TRANSACTION.\n\nThis press release does not contain all the information that should be\nconsidered concerning the Proposed Transaction and related matters and is not\nintended to provide the basis for any investment decision or other decision\nconcerning such matters.\n\nInvestors and shareholders may obtain copies of the Definitive Proxy Statement\nand other relevant filings free of charge at www.sec.gov or by submitting a\nrequest to HeartSciences Investor Relations at\ninvestorrelations@heartsciences.com.\n\nCautionary Note Regarding Forward-Looking Information\n\nThis press release contains forward-looking statements concerning\nHeartSciences, Fortitude, the Proposed Transaction and other matters.\n\nForward-looking statements may be identified by terms such as \"anticipate,\"\n\"expect,\" \"plan,\" \"will,\" \"would,\" \"believe,\" \"estimate,\" \"goal,\" \"intend,\"\nand similar expressions. Statements other than historical facts should be\nconsidered forward-looking statements.\n\nThese statements include, without limitation, expectations regarding the\ntiming and completion of the Proposed Transaction, the anticipated benefits of\nthe Proposed Transaction, the future operations and strategy of the combined\ncompany, and the expected Nasdaq listing and trading symbol.\n\nForward-looking statements are based on management's current expectations and\nassumptions and are subject to risks, uncertainties and other factors that\ncould cause actual outcomes to differ materially from those expressed or\nimplied.\n\nThese risks include, among others:\n* The possibility that the Proposed Transaction may not be completed on the\nanticipated timeline or at all;\n* Failure to satisfy closing conditions, including obtaining the necessary\nHeartSciences shareholder approvals and applicable Nasdaq listing approvals;\n* Market, macroeconomic and business conditions affecting HeartSciences,\nFortitude or the combined company;\n* Risks associated with integrating operations and managing a newly public\ncompany;\n* Risks related to Fortitude's mining operations, including the substantial\nvolatility of Zcash and other digital asset prices; and\n* Legal, commercial, regulatory and technical uncertainties associated with\ndigital assets.\nAdditional risks and uncertainties are described in the Definitive Proxy\nStatement, HeartSciences' Annual Report on Form 10-K filed July 23, 2026, its\nQuarterly Report on Form 10-Q filed September 14, 2026, and other SEC filings.\n\nReaders are cautioned not to place undue reliance on forward-looking\nstatements. HeartSciences and Fortitude undertake no obligation to update or\nrevise forward-looking statements except as required by applicable law. All\nforward-looking statements speak only as of the date of this release.\n\nParticipants in the Solicitation\n\nHeartSciences and Fortitude, their respective directors and executive\nofficers, and certain executive officers of Digital Currency Group (“DCG”)\n, Fortitude's parent company, may be deemed participants in the solicitation\nof proxies from HeartSciences shareholders in connection with the Proposed\nTransaction.\n\nInformation regarding these participants and their direct or indirect\ninterests in the Proposed Transaction, whether through securities holdings or\notherwise, is described in the Definitive Proxy Statement and other relevant\nSEC filings.\n\nAbout Fortitude\n\nFortitude, currently wholly owned by DCG, is an institutional-scale,\nvertically-integrated venture mining platform operating across the\nProof-of-Work ecosystem and anchored in Zcash. Fortitude pairs self-mining\noperations with an owned data center footprint, a diversified power portfolio\nbacked by competitive long-term contracts, and disciplined capital allocation\nto identify and scale high-conviction opportunities in emerging Proof-of-Work\necosystems, beginning with its leadership position in the Zcash network.\nFortitude is led by an experienced team of operators, capital markets\nprofessionals, and digital asset specialists with a track record of\nidentifying and scaling high-conviction opportunities and building\nprivacy-preserving digital asset infrastructure.\n\nFor more information, visit www.fortitudemining.com and follow Fortitude on X\nat @FortitudeCrypto\n\nIn the ordinary course of business, Fortitude currently sells or otherwise\nmonetizes all the digital assets that it mines, including ZEC. In addition,\nFortitude and its affiliates and subsidiaries, including DCG, from time to\ntime sell, pledge or otherwise monetize their digital asset holdings,\nincluding ZEC. The funds received from such sales, pledges, or other\nmonetization activities are used to fund operating expenses and capital\ninvestments, as well as for other purposes, including to hedge exposures and\nrealize investment gains.\n\nAbout HeartSciences Inc.\n\nHeartSciences is a healthcare information technology company advancing the use\nof electrocardiography (\"ECG\" or \"EKG\") through the integration of artificial\nintelligence. HeartSciences' MyoVista Insights™ platform is a\ndevice-agnostic ECG management system designed to improve clinical efficiency\nand decision-making. Its MyoVista wavECG device is designed to deliver\nconventional ECG functionality while supporting AI-enabled solutions.\n\nFor more information, visit www.heartsciences.com\n\nInvestor Relations Contact\nIntegrous Communications\nMark Komonoski, Partner\nPhone: 877 255 8483\nEmail: mkomonoski@integcom.us \n\nEmail: investorrelations@heartsciences.com\n\nFortitude Investor Relations and Media Contact:\nICR\nPhone: 917-375-9457\nEmail: IR@fortitudemining.com\n\nA photo accompanying this announcement is available at\nhttps://www.globenewswire.com/NewsRoom/AttachmentNg/dd7e1d4a-bc27-4a05-baa5-902736cdec1b\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/800a6aae-74f3-42bb-9199-5e169ed9b881)\nOkapi Partners LLC Logo \n(https://www.globenewswire.com/NewsRoom/AttachmentNg/dd7e1d4a-bc27-4a05-baa5-902736cdec1b/en)\nOkapi Partners LLC Logo\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-10-21T12:30:00.861330134Z","server_sent_at_ms":1792585800861},"received_at":"2026-10-21T12:30:00.919Z","source_url":null},"analysis":{"id":"163561","press_release_id":"175548","analysis_json":{"industry":null,"redFlags":["Filer pivots from AI-medtech to crypto mining — full change of business model and risk profile","Zcash/digital asset price volatility explicitly cited as a risk; Fortitude currently monetizes all mined ZEC","Deal completion not assured — shareholder and Nasdaq approvals still pending","Existing HSCS medtech shareholders face dilution/exchange into a crypto mining vehicle; exchange ratio not disclosed in this release"],"eventType":"m_and_a","narrative":"HeartSciences filed its definitive proxy statement with the SEC for the proposed all-stock business combination with Fortitude Mining Holdings, first announced June 23, 2026.\n\nA virtual special meeting is set for November 19, 2026, with the board unanimously recommending shareholders vote FOR the transaction proposals; record date is October 8, 2026.\n\nUpon closing, the combined company will operate as Fortitude — a vertically integrated Zcash-anchored digital asset mining platform wholly divested by DCG — and trade on Nasdaq under the ticker TUDE, replacing the current medtech business identity.\n\nCompletion remains subject to shareholder approval, Nasdaq listing requirements and customary closing conditions.","sentiment":"mixed","agentHooks":{"shouldPost":true,"suggestedAngle":"Medtech shell becomes a Zcash miner: HSCS proxy filing clears the path to a TUDE-listed Fortitude — watch the Nov. 19 vote."},"keyFigures":{"customDimensions":{"new_ticker":"TUDE","record_date":"October 8, 2026","special_meeting_date":"November 19, 2026","transaction_structure":"all-stock"}},"quotedText":"Proposed combination expected to establish a publicly traded, vertically-integrated digital asset mining platform focused on Zcash, subject to shareholder approval and other closing conditions","namedEntities":{"people":[{"name":"Mark Komonoski","role":"Partner, Integrous Communications (IR contact)"}],"products":["MyoVista Insights","MyoVista wavECG","Zcash (ZEC)"],"companies":[{"name":"HeartSciences Inc.","ticker":"HSCS","relationship":"filer / acquirer in all-stock combination"},{"name":"Fortitude Mining Holdings, Inc.","relationship":"merger target; combined company to carry Fortitude brand"},{"name":"Digital Currency Group (DCG)","relationship":"Fortitude's parent company"},{"name":"Okapi Partners LLC","relationship":"proxy solicitor"},{"name":"ICR","relationship":"Fortitude IR/media contact"}],"dollarAmounts":[]},"materialImpact":{"score":4,"reasoning":"Definitive proxy filed for an all-stock business combination that will transform HeartSciences from an AI-ECG medtech company into a Zcash-focused digital asset miner trading as TUDE. Material strategic pivot for the filer, with shareholder vote set for Nov. 19, 2026."},"tickerRelevance":{"others":[],"primary":"HSCS"},"globalImportance":35,"audienceRelevance":40,"eventTypeSecondary":["other"],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"proxy filing milestone in pending M&A / business-model transformation","issuerAuthored":true,"retailFavoriteBoost":"crypto pivot likely draws retail attention"}},"event_type":"m_and_a","event_type_secondary":["other"],"sentiment":"mixed","material_impact_score":4,"narrative":"HeartSciences filed its definitive proxy statement with the SEC for the proposed all-stock business combination with Fortitude Mining Holdings, first announced June 23, 2026.\n\nA virtual special meeting is set for November 19, 2026, with the board unanimously recommending shareholders vote FOR the transaction proposals; record date is October 8, 2026.\n\nUpon closing, the combined company will operate as Fortitude — a vertically integrated Zcash-anchored digital asset mining platform wholly divested by DCG — and trade on Nasdaq under the ticker TUDE, replacing the current medtech business identity.\n\nCompletion remains subject to shareholder approval, Nasdaq listing requirements and customary closing conditions.","key_figures":{"customDimensions":{"new_ticker":"TUDE","record_date":"October 8, 2026","special_meeting_date":"November 19, 2026","transaction_structure":"all-stock"}},"named_entities":{"people":[{"name":"Mark Komonoski","role":"Partner, Integrous Communications (IR contact)"}],"products":["MyoVista Insights","MyoVista wavECG","Zcash (ZEC)"],"companies":[{"name":"HeartSciences Inc.","ticker":"HSCS","relationship":"filer / acquirer in all-stock combination"},{"name":"Fortitude Mining Holdings, Inc.","relationship":"merger target; combined company to carry Fortitude brand"},{"name":"Digital Currency Group (DCG)","relationship":"Fortitude's parent company"},{"name":"Okapi Partners LLC","relationship":"proxy solicitor"},{"name":"ICR","relationship":"Fortitude IR/media contact"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-21T12:30:18.034Z","global_importance":35,"audience_relevance":40,"importance_components":{"tickerTier":"small-cap","eventGravity":"proxy filing milestone in pending M&A / business-model transformation","issuerAuthored":true,"retailFavoriteBoost":"crypto pivot likely draws retail attention"}},"durationMs":7003,"modelName":"glm-5.3-flashx"}}